This article reports a rare case of late-onset tubercular infection following total knee arthroplasty in a 60-year-old woman who had been treated with a full course of antitubercular therapy for latent tuberculosis almost 25 years ago. Because no clear guidelines exist for optimal management of disease reactivation in the prosthetic knee joint, the authors performed a literature review and attempted to provide a treatment algorithm based on the time of presentation. Two modes of presentation were identified for unsuspected tubercular prosthetic joint infections based on the onset of symptoms and time to diagnosis: an early-onset presentation that occurs within the first 6 to 8 weeks postoperatively and a late-onset presentation that usually manifests after 8 weeks. Early-onset presentations often can be treated with standard antitubercular chemotherapy alone, whereas late-onset presentation may require 2-stage reimplantation under cover of antitubercular medications. This report also highlights the fact that despite adequate treatment of latent tuberculosis, patients may remain at risk of prosthetic joint infection following total knee arthroplasty.
T ubercular prosthetic joint infection following total knee arthroplasty (TKA) is an uncommon clinical presentation in the United States. Most authors consider reactivation of quiescent infection in the knee joint as the primary pathogenetic mechanism for the recurrence of this disease. [1] [2] [3] [4] [5] Few authors have reported that hematogenous spread from extra-articular focus can also lead to seeding of the prosthetic joint. 4, 6, 7 However, reactivation of tubercular infection following TKA in a patient with a history of treated latent tubercular infection is rare and has not been widely reported in the literature.
Identification of tubercular prosthetic joint infection is often demanding due to a lack of clinical suspicion, varied presentation, and the presence of concomitant secondary bacterial infections. 1 This often leads to a delay in the diagnosis and initiation of treatment. Moreover, no clear guidelines exist for the optimal management of disease reactivation in the prosthetic knee joint. Some authors have suggested that a prolonged course of antitubercular chemotherapy alone may be adequate to eradicate the infection. 6, 8 However, others believe that a 2-stage revision TKA with an extended course of antitubercular chemotherapy is necessary to eradicate the disease. 1, 9 Currently, a paucity exists of reports that have comprehensively described the varied presentations and the treatment options for tubercular reactivation in the prosthetic knee joint. [1] [2] [3] [4] [5] The current report presents a case of late-onset prosthetic joint tubercular infection in a patient who had a prior history of treated latent tuberculosis. A brief algorithm was developed to guide management of these challenging infections based on the time of presentation and final diagnosis.
Case RepoRt
A 60-year-old woman presented with a history of right knee pain of several years' duration that was unresponsive to nonoperative management. Her medical history was noncontributory other than mild hypertension. The knee examination revealed no swelling, effusion, abnormal warmth, or instability. Range of motion was painful from 5° of extension to 120° of flexion; Knee Society pain and functional scores were 64 and 80 points, respectively. A valgus deformity of 15° with collapse of the lateral joint space and tricompartmental osteoarthritic changes were found on the initial radiographs, which were compatible with a provisional diagnosis of primary osteoarthritis ( Figure  1 ). After discussing the risks, benefits, and alternatives, the patient consented to undergo TKA.
In April 2008, she underwent TKA with a posterior-stabilized cemented TKA (Triathlon; Stryker Orthopaedics, Mahwah, New Jersey). Intraoperatively, the synovium was moderately hypertrophic and hyperemic with some evidence of pannus formation over the medial and lateral femoral condyles. Some fibrinous exudate was present, suggestive of rheumatoid arthritis. Histopathologic examination of the fibrinous material and synovium revealed nonspecific inflammatory changes. Gram stain and aerobic and anaerobic cultures from the tissue samples obtained intraoperatively were negative. Postoperative radiographs revealed satisfactory position and alignment of the prosthesis (Figure 2) . The patient made a full recovery, and at 3 months postoperatively, she had returned to her normal activities.
Seven months postoperatively, the patient presented with a painless, firm, 434-cm mass on the medial aspect of the proximal tibial metaphysis. Knee examination revealed no effusion, loss of motion, or instability. Radiographs showed no evidence of osteolysis, loosening, or change in alignment from immediate postoperative radiographs. Serologic markers for infection (erythrocyte sedimentation rate and C-reactive protein) were within normal range. Aspiration of the mass revealed clear yellow fluid with normal cell counts and Gram stain. No growth occurred from the specimens obtained intraoperatively.
The mass recurred, and in March 2009, computed tomography (CT) demonstrated a 6.233.9-cm noncommunicating cystic mass at the level of the knee joint deep to the pes anserinus ( Figure 3 ). Surgical exploration was advised, but the patient refused surgical treatment. In October The patient agreed to undergo reoperation, and exploratory surgery was performed. Intraoperatively, the cystic mass had a broad sessile base, and 10 cm 3 of purulent fluid was aspirated ( Figure 5 ). Within the mass, caseating material was observed on visual inspection. However, intraoperative Gram stain was negative for organisms. Tissue samples for aerobic, anaerobic, fungal, and tubercular cultures were obtained. Before exploring the joint further, a decision was made to wait for final culture results. Two months postoperatively, in March 2010, the wound had broken down with a persistent sinus that subsequently was debrided, and a vacuum-assisted-closure dressing was applied. At this time, cultures obtained during the previous surgical exploration came back as positive for Mycobacterium tuberculosis. Antitubercular treatment was started with a 4-drug regimen consisting of rifampicin, isoniazid, ethambutol, and pyrazinamide. At this point, the patient recalled that approximately 25 years ago as a social worker, she had a single, brief contact with a client who subsequently was identified as having pulmonary tuberculosis. She was treated with antituberculous medication for 1 year although she never had a positive tuberculin test or symptoms of active tubercular disease.
In July 2010, debridement and removal of the implants were performed and a tobramycin-containing antibiotic-articulating cement spacer was inserted. She remained on antitubercular therapy until March 2011 to complete a 1-year course of drug treatment. Following completion of preoperative drug therapy, aspiration from the knee revealed 5 mL of clear yellow fluid. Gram stain, Ziehl-Neelsen stain, and culture and sensitivities for all pathogens, including mycobacterium, were negative. In April 2011, under antitubercular coverage, revision arthroplasty was performed with hybrid fixation, cementing the distal portion of the femur and proximal tibia, with large, canal filling press-fit stems (Triathlon TS; Stryker Orthopaedics). Distal and posterior femoral augments were needed in addition to medial and lateral block augments for the tibia. Gram stain, Ziehl-Neelsen stain, and pyogenic and tubercular cultures were negative from tissue samples obtained during reimplantation. Postoperatively, antitubercular chemotherapy with isoniazid and rifampicin was continued for 9 months.
Two years postoperatively, the patient was pain free, with a range of motion from 5° of extension to 120° of flexion and with Knee Society pain and functional score of 90 and 85 points, respectively. She had returned to her usual activities of daily living. Radiographs revealed that the implants were stable with no osteolysis or loosening ( Figure 6 ). Appropriate institutional review board approval was obtained prior to preparation of this article.
DisCussion
Tubercular prosthetic joint infections usually result from local reactivation of quiescent infections (group A) or hematogenous spread from an extrapulmonary or a pulmonary focus (groups B and C) ( Figure 7) . 2, 3, 9, 10 Reactivation often occurs many years after an apparent symptom- free period and may be associated with surgical trauma. 3 Lack of clinical suspicion, inability to confirm the diagnosis even if clinically suspected, and coinfection with pyogenic bacteria from a chronically discharging sinus often lead to a delay in diagnosis.
11 Due to the rare nature of these infections and the lack of clear evidence, formulating treatment guidelines for these prosthetic joint infections are difficult. 2, 9, 10, 12, 13 The aim of this study was to report a rare presentation of lateonset of tubercular reactivation following TKA in a patient who was treated previously for latent tuberculous infection. A comprehensive review of the literature regarding the varied onsets of presentation of tubercular prosthetic joint infections and the optimal management of these infections was also conducted.
The literature review on prosthetic joint tubercular infections identified 2 distinct modes of presentation (Figure 7 ; Table) : early presentation (6 to 8 weeks) in the postoperative period or a delayed onset after 2 months. 2, 6, 8, 12, [14] [15] [16] Late-onset presentation is often associated with radiographic evidence of osteolysis or implant loosening; in contrast, patients with early-onset presentation tend to have a stable prosthesis. High clinical suspicion of an indolent intra-articular infection during surgery may lead to an early diagnosis in some cases from positive cultures or histopathologic evidence of caseating granulomas in tissue samples obtained intraoperatively. 6, 9, 14 When these infections are diagnosed early in the postoperative period (less than 2 months postoperatively), most authors have reported eradication of infection with surgical debridement and chemotherapy without the need for prosthesis removal. 2, 6, 12, 14 Wray and Roy, 6 in their report of 2 patients at mean follow-up of 3 years (range, 1.5-5 years), found complete eradication of tubercular prosthetic joint infection of the knee with a 12-month course of antitubercular chemotherapy. The tubercular etiology was confirmed from the histopathologic examination of the tissue specimens obtained intraoperatively in both of these patients. Importantly, neither of these patients had a discharging sinus or evidence of osteolysis or implant loosening at presentation. 6 Lee et al 2 reported early reactivation of tubercular infection (8 weeks) in a 79-yearold woman who had no evidence of tubercular infection prior to undergoing TKA. The tubercular etiology was confirmed from histologic specimens obtained during irrigation and debridement for early prosthetic joint infection. They reported suppression of infection at 13 months postoperatively with antitubercular drugs without the need for prosthesis removal. 2 These reports indicate that when a diagnosis is made early in the postoperative period from intraoperative cultures or histopathologic examination of tissue specimens, treatment with chemotherapy alone may be appropriate. In the presence of persistent early postoperative discharge, standard surgical principles of wound management should be followed. This may involve exploration, irrigation, debridement, synovectomy, and polyethylene exchange with antitubercular chemotherapy (for at least 12 months). However, in the presence of implant loosening, osteolysis, super-added pyogenic infections, or a chronic discharging sinus, consideration may be given to a 2-stage revision arthroplasty, even if the disease presents itself early in the postoperative period. 17 Controversy exists regarding the optimal method of treatment when these infections are diagnosed late (more than 2 months) in the postoperative period. [2] [3] [4] 8, 17 Neogi et al 8 reported no recurrence of infection in a 73-year-old patient 3 years postoperatively following prolonged antitubercular treatment (18 months) for lateonset presentation 14 years after TKA. Spinner et al 17 similarly reported suppression of tubercular infection at 2.5 years postoperatively, with multiple debridements and prolonged chemotherapy (12 months) in a 70-year-old patient who presented with persistent purulent discharging sinus 4 years following revision TKA. 
